Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.36%), DAX (0.93%), CAC40 (0.02%)

Nov 04 ,2025

  • Synopsis

    • European equity markets are set to open flat to lower amidst Asia equities lower Tuesday.

    • UK Chancellor Reeves will hold a rare pre-Budget press conference in early Europe to lay the ground for tax increases (Telegraph, BBC). She will set out three priorities - cutting the NHS waiting list, reducing national debt and improving the cost of living (London Times). She will acknowledge recent speculation on tax increases and insist she will take the necessary steps to right public finances for years to come. Comes after PM Starmer's official spokesman refused on Monday to stand by Labour's pledge not to increase income tax, National Insurance or VAT. Starmer put Labour MPs on alert at a private meeting on Monday that the backdrop to the budget was worse than expected. However, he said it would reject deep cuts to public services and the NHS would be protected, as Downing Street coordinates with the Treasury (FT).

    • Also on today's agenda, Chancellor Merz continues his inaugural visits to the German states, this time to Mecklenburg-Western Pomerania. In UK, business in the House of Commons kicks off at 11:30GMT with Chancellor Reeves facing MPs questions on Treasury and there's a debate on a motion in the name of the Official Opposition (subject tba). Committee topics include AI in financial services 14:15 and the UK's fiscal framework 15:00. EU's Jørgensen speech at the Strategic Energy Technology Plan (SET-Plan) Conf. NATO North Atlantic Council meeting, sees EU's Kubilius among the attendees. EU's Dombrovskis, ESM's Gramegna participate in Bulgaria central bank's conf 'Bulgaria on the Doorstep of the Eurozone', ECB's Lagarde speech at 8:40CET, press conf 10:45 (event webcast (English) or Bulgarian). EU's Tzitzikostas presents the High Speed Rail Master Plan and the Sustainable Transport Investment Plan (STIP). Norway's Sandvik among the defence ministers from the ten JEF countries attending meeting (through Wed) to strengthen cooperation and security in Northern Europe, whilst minister of fisheries and the oceans Næss participates in Agenda Nord-Norge and minister of finance Stoltenberg participates in debate at the Storting about the Government Pension Fund Global's investments in Israeli companies. PM Støre speaks at 13:00CET at Yara's autumn seminar and minister of energy Aasland participates in the National Tariff Conf for the Energy Sector, organized by the Electricity and IT Assn. Amongst events on Tue, Handelsblatt Health (through Wed) and Handelsblatt Industry (through Wed), as well as Dagens industri's AI Customer Experience Summit and Small Business Evening.

    • In central banks, Cyprus central bank's Patsalides speech at 8:55CET at The Economist's 21st Annual Cyprus Summit. Bank of Spain's Escrivá speech at 10:00CET at conf. organised by Santander, with BOE's Breeden in fireside chat at 12:40CET. Bundesbank's Balz speech at 13:00CET at conf. on Digital Euro organised by the bank whilst Bundesbank's Nagel speech at 18:00CET title 'Together we are stronger - how Europe is becoming fit for its new global role' at event organised by the bank.

    • European macro data releases include Spain Oct unemployment change.

    • Market taking somewhat cautious view of latest round of high-profile AI updates. No traction from AMZN's $38B deal with OpenAI giving ChatGPT maker access to Amazon's data centers. GOOGL plans to raise around $22B through debt markets put more scrutiny on ramp in AI-linked issuance and related credit market risks. PLTR -4% afterhours and weighing on Nasdaq futures. Group guided Q4 revenue above expectations citing accelerating demand for AI and data analytics products, though high valuation and lack of clarity on 2026 guidance among early talking points.

    • A busy morning for earnings, the DACHs region kicked off the session with Fresenius Medical Care (FME.GR), Nemetschek (NEM.GR), Evonik Industries (EVK.GR), Nordex (NDX1.GR) and Hugo Boss (BOSS.GR) reporting Q3 earnings. In the Netherlands, Philips (PHIA.NA) issued Q3 earnings numbers and reiterated FY25 outlook with EBITA margin now expected at the upper end of the range. In France, bioMerieux (BIM.FP) released its Q3 revenue and lowered its FY sales outlook, whilst Edenred provided new 2025-28 Outlook with its Amplify25-28 plan in connection with its CMD today. In Nordics, Coloplast (COLO.B.DC) reported Q4 earnings and SSAB (SSAB.A.SS) issued a presentation in connection with its CMD. In Spain, Telefonica (TEF.S) reported Q3 earnings and reaffirmed FY revenue, EBITDA, capex guidance and dividend commitment for 2025. Also outlined longer term targets ahead of its CMD.

    • In M&A, Apollo (APO) announced that Apollo-managed funds have agreed to invest $6.5B in a 50% stake in Ørsted's (ORSTED.DC) Hornsea 3.

  • Politics/Macro/World News

    • Chancellor Rachel Reeves to set out priorities in pre-Budget speech - BBC

    • UK's Poorest Areas Turn En Masse Toward Nigel Farage's Reform - Bloomberg

    • Jumble of tax proposals snarls up France's painful budget process - FT

    • EU in last-minute talks to set new climate goal for COP30 - Reuters

  • Top company news

    • Earnings/updates

      • DACHs

        • FME.GR (Fresenius Medical Care) -- reports Q3 EPS €0.94 vs consensus €0.86; outlook 2025 confirmed

        • NEM.GR (Nemetschek) -- reports Q3 EPS €0.48 vs FactSet €0.46 [7 est, €0.41-0.53]

        • NDX1.GR (Nordex) -- reports final Q3 earnings in line with prelim. release: net income €51.7M vs FactSet €49.1M [3 est, €47-52M]

        • OERL.SW (OC Oerlikon Corp.) -- reports Q3 revenue CHF380M vs FactSet CHF376.0M [3 est, CHF368-383M]

        • ADV.GR (Adtran Networks) -- guides FY pro forma EBIT low negative to low positive single-digit percentage of revenue

        • ADV.GR (Adtran Networks) -- reports Q3 pro forma EBIT €3.8M vs year-ago (€4.1M)

        • BCHN.SW (Burckhardt Compression Holding) -- reports H1 EPS CHF14.40 vs FactSet CHF11.44 [1 est]

        • SFQ.GR (SAF-HOLLAND) -- reports preliminary 9M EBIT €121.1M vs €146.1M year-ago

        • GEBN.SW (Geberit) -- reports Q3 net income CHF155.8M vs StreetAccount CHF154.2M; now expects FY Net sales growth in local currencies of around +4.5% vs prior guidance +4%

        • EVK.GR (Evonik Industries) -- reports Q3 adjusted EPS €0.27 vs consensus €0.26

        • ATS.AV (AT & S Austria Technologie & Systemtechnik) -- reports Q2 net income (€7.6M) vs FactSet (€13M) [1 est]; comments on FY25/26 and FY26/27 outlook

        • GF.SW (Georg Fischer) -- provides a deep dive into its new Strategy 2030; targets EBITDA margin 16-18% - CMD

        • NOEJ.GR (Norma Group) -- reports Q3 adj. EPS from continuing operations €0.05 vs FactSet (€1.03) [2 est, (€2.12)-0.06]

        • RSL2.GR (R. Stahl) -- reports Q3 EPS €0.39 vs year-ago €0.28; confirms FY outlook

        • BOSS.GR (Hugo Boss) -- reports Q3 EPS €0.85 vs consensus €0.82; now expects FY25 Group sales and EBIT to align with lower ends of guidance ranges

        • ELG.GR (Elmos Semiconductor) -- reports Q3 EPS €1.37 vs FactSet €1.34 [1 est]; guides FY25

      • Benelux

        • PHIA.NA (Koninklijke Philips) -- reports Q3 EPS €0.36 ex-items vs consensus €0.32; reiterates FY25 outlook with EBITA margin now expected at the upper end of the range

        • THEON.NA (Theon International) -- reports 9M EPS €0.70 vs year-ago €0.56

        • WHA.NA (Wereldhave) -- reports 9M DRPS €1.36 vs year-ago €1.30

      • France

        • BIM.FP (bioMerieux) -- reports Q3 revenue €948.1M vs FactSet €975.8M [5 est, €951-997M]. Lowers FY sales outlook

        • VCT.FP (Vicat) -- reports Q3 revenue €992M vs year-ago €979M

        • COFA.FP (Coface) -- reports 9M net income €176.3M, (15%) vs year-ago €207.7M

        • BEN.FP (Beneteau) -- reports Q3 revenue €170.6M vs FactSet €185.0M [1 est]; expects H2 income from ordinary operations to be positive

        • EDEN.FP (Edenred) -- provides new 2025-28 Outlook with its Amplify25-28 plan

      • Nordics

        • ORSTED.DC (Ørsted) -- Follow-up: Ørsted issues press release on agreement to divest 50% stake in Hornsea 3 to Apollo

        • BAKKA.NO (Bakkafrost) -- reports Q3 operational EBIT DKK22M vs FactSet DKK82.1M [12 est, DKK22-105.3M]

        • BOOZT.SS (Boozt Fashion) -- reports Q3 EPS SEK0.69 vs FactSet SEK0.66 [3 est, SEK0.59-0.70]; updates FY outlook

        • NRC.NO (NRC Group) -- reports Q3 EPS NOK0.17 vs FactSet NOK0.22 [3 est, NOK0.19-0.26]

        • MULTI.NO (Multiconsult) -- reports Q3 EPS NOK1.41 vs FactSet NOK1.63 [4 est, NOK1.00-2.14]

        • AKER.NO (Aker ASA) -- reports Q3 NAVPS NOK909, +19% vs year-ago NOK767

        • BICO.SS (BICO Group) -- reports Q3 EPS cont ops (SEK15.68) vs year-ago (SEK3.68)

        • SMCRT.NO (SmartCraft) --reports Q3 net income NOK23.4M vs FactSet NOK26.6M [6 est, NOK25.3-28.3M]

        • CLOUD.NO (Cloudberry Clean Energy) -- reports Q3 EPS NOK0.27 vs year-ago (NOK0.06)

        • IPCO.SS (International Petroleum Corp) -- reports Q3 net income $3.8M vs FactSet $6.6M [7 est, ($1)-17M]

        • COLO.B.DC (Coloplast) -- reports Q4 net income DKK875M vs consensus DKK968M; guides FY26/26

        • SSAB.A.SS (SSAB) -- reiterates its financial targets; targets increase in premium offering as percent of the Group's total shipments - CMD

        • ARCH.NO (Archer) -- reports Q3 adjusted EBITDA $40.2M, +11% y/y; reiterates FY25 financial guidance

        • HACK.SS (Hacksaw) -- reports Q3 EPS €0.13 vs year-ago €0.11

        • NORB.B.SS (Nordisk Bergteknik) -- reports Q3 EPS SEK0.18 vs FactSet SEK0.01 [2 est, SEK0.00-0.02]

      • Southern Europe

        • LTMC.IM (Lottomatica Group) -- reports 9M adjusted net income €257.4M ex-items, +60% vs year-ago €161M

        • TEF.SM (Telefonica) -- reports Q3 adj. EBITDA €3.07B vs consensus €3.04B; reaffirms FY revenue, EBITDA, capex guidance and dividend commitment for 2025

      • Also due to report today includes:

        • Earnings:

          • Austria Mayr-Melnhof Karton (MMK.AV)

          • Denmark North Media (NORTHM.DC)

          • Finland NoHo Partners (NOHO.FH)

          • France Transgene (TNG.FP)

          • Germany , Schaeffler (SHA0.GR), Aura Minerals (A531.GR), NEXUS (NXU.GR), AdvancedAdvT (06P0.GR), Mediclin (MED.GR), CENIT (CSH.GR)

          • Norway Cloudberry Okea (OKEA.NO)

          • Southern Europe: Grifols (GRF.SM), Gestamp Automoción (GEST.SM), FinecoBank (FBK.IM), Banca Popolare di Sondrio (BPSO.IM), Industrie De Nora (DNR.IM), Public Power Corp. (PPC.GA)

          • Sweden Latour Investment (LATO.B.SS), Cibus Nordic Real Estate (CIBUS.SS), Nobia (NOBI.SS), Studsvik (SVIK.SS), SaltX Technology Holding (SALT.B.SS), Embellence Group (EMBELL.SS), 4C Group (4C.SS), Catena Media (CTM.SS)

          • Switzerland Burckhardt Compression Holding (BCHN.SW),

          • UK: BP (BP.LN), Associated British Foods (ABF.LN), dotDigital Group (DOTD.LN), Smiths News (SNWS.LN), Focusrite (TUNE.LN)

        • Trading Update:

          • Benelux: Alfen (ALFEN.NA)

          • France: Rubis (RUI.FP), Oeneo (SBT.FP)

          • Nordics: Archer (ARCH.NO), Demant (DEMANT.DC),NNIT (NNIT.DC)

          • Southern Europe: Safilo Group (SFL.IM)

          • UK: International Workplace Group (IWG.LN), Domino's Pizza Group (DOM.LN)

          • Other: AIB Group (A5G.ID)

        • Sales: Volvo Car (VOLV.B.SS)

        • CMD/events: Telefonica (TEF.SM), AFRY (AFRY.SS), Indutrade (INDT.SS), HEXPOL (HPOL.B.SS), Kardex Holding (KARN.SW), Enento Group (ENENTO.FH), Aspocomp Group (ACG1V.FH),

    • M&A

      • ORSTED.DC (Ørsted) -- Apollo funds commit $6.5B to Ørsted's Hornsea 3

      • NB2.GR (Northern Data) -- Group announces agreement for divestiture of Peak Mining for up to USD$200M

      • GCO.SM (Grupo Catalana Occidente) -- Grupo Catalana Occidente's board of directors publishes favorable opinion on Inoc's offer with the unanimous vote of the monitoring committee (earlier)

      • FSG.LN (Foresight Group Holdings) -- TPG confirms acquisition of 70% equity interest in Kinetic Group; terms undisclosed

      • NRG (NRG Energy) -- in talks with a buyer for the Gladstone power station -- Australian Financial Review

      • AENA.SM (Aena S.M.E.) -- Aena S.M.E.notes Grupo Aeroportuario del Pacífico proposes the business combination of the Cross Border Xpress and the technical assistance services

      • WG.LN (John Wood Group) -- provides update on sale of joint venture interest in RWG to Siemens Energy Global

      • ONTEX.BB (Ontex Group) -- completes divestment of Turkish business

      • OERL.SW (OC Oerlikon Corp.) -- reports Q3 revenue CHF380M vs FactSet CHF376.0M [3 est, CHF368-383M]

      • ACKB.BB (Ackermans & Van Haaren) -- notes DEME announcement regarding ownership realignment among shareholders in the ScotWind project

      • KIN.BB (Kinepolis Group) -- Kinepolis to buy Emagine Entertainment at transaction value of $105M (€91.2M) plus up to $15M growth-based earn-out

      • SEI.CN (Sintana Energy) -- Challenger Energy Group and Sintana Energy provide update surrounding previously announced acquisition of Challenger by Sintana

      • FSG.LN (Foresight Group Holdings) -- TPG to acquire 70% of Kinetic Group at more than A$4B (£1.99B/$2.62B) valuation - Australian Financial Review

      • DEME.BB (DEME Group) -- provides update on ScotWind project

      • IF.IM (Banca Ifis) -- announces illimity Bank accepts Banca Sella Holding's offer to acquire a 50% stake in Hype

      • BELL.SW (Bell Food Group) -- agrees to acquire the production facility of Hermann Wein GmbH & Co. KG in Freudenstadt as part of an asset deal

    • Healthcare

      • UCB.BB (UCB) -- FDA approves Kygevvi as treatment for TK2d in adults and pediatric patients

        • UCB.BB (UCB) -- FDA issues press release highlighting first drug approval for rare disease TK2d

        • UCB.BB (UCB) -- Follow-up: U.S. FDA approves KYGEVVI as treatment for TK2d in adults and pediatric patients; availability and RPDPRV voucher status

      • ABVX.FP (Abivax) -- announces patient-reported Ph3 data of Obefazimod in moderate-to-severely active ulcerative colitis

      • VLA.FP (Valneva) -- reports positive results for Phase 1 Trial of Second-Generation Zika vaccine candidate

      • SANN.SW (Santhera Pharmaceuticals Holding) -- Santhera Pharmaceuticals announces five-year data of AGAMREE (vamorolone) in patients with DMD show improved safety profile with comparable effectiveness to standard of care corticosteroids

      • OXUR.BB (Oxurion) -- terminates discussions regarding planned acquisition of company specialized in preclinical microbiology services

    • Other

      • NOKIA.FH (Nokia) -- announces intention to seek a delisting from Paris Stock Exchange

      • AIR.FP (Airbus SE) -- Airbus reportedly delivered 78 planes in October -- Bloomberg

      • BBVA.SM (Banco Bilbao Vizcaya Argentaria) -- has agreed to carry out an issue of €1.0B preferred securities contingently convertible into newly issued ordinary shares of BBVA

      • EDP.PL (EDP-Energias de Portugal) -- signs deal with Heineken and Rondo Energy to decarbonize brewery emissions

      • FBK.IM (FinecoBank) -- publishes 2026 SREP requirements; capital ratios well above the capital requirements assigned by the ECB

      • Italy Oct new passenger car registrations 126,543; (0.6%) y/y; guides 2025 and 2026 -- UNRAE

      • Spain Oct new passenger car registrations 96,785 units, +15.9% y/y - ANFAC (earlier)

  • Key rating changes

    • Upgrades

      • MONC.IM (Moncler) -- to overweight from equal weight at Barclays

      • FORTUM.FH (Fortum) -- to neutral from underperform at BNP Paribas Exane

      • PAH3.GR (Porsche Automobil Holding SE) -- to neutral from sell at UBS

      • RYA.ID (Ryanair Holdings) -- to buy from hold at Peel Hunt

      • SOBI.SS (Swedish Orphan Biovitrum) -- to buy from hold at Deutsche Bank

      • STMN.SW (Straumann Holding) -- to neutral from sell at UBS

    • Downgrades

      • PBB.GR (Deutsche Pfandbriefbank) -- to reduce from hold at Kepler Cheuvreux

      • RMS.FP (Hermes) -- to equal weight from overweight at BNP Paribas Exane

    • Initiations

      • AMRZ.SW (Amrize) -- neutral at Oddo

  • Data

    • Nikkei (1.74%) to 51497.20

    • Hang Seng (0.78%) to 25955.43

    • Shanghai Composite (0.74%) to 3947.17

    • S&P futures (62.0) vs prior close of 6882.8

    • €-$ +0.0004 or +0.03% to 1.1523

    • $-¥ (0.56) or (0.36%) to 153.65

    • €-¥ (0.60) or (0.34%) to 177.04

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE